Vespa crabro chromosome 20, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342419.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
uncharacterized LOC124431256, transcript variant X4
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC124431256, transcript variant X3
uncharacterized LOC124431256, transcript variant X5
uncharacterized LOC124431256, transcript variant X1
uncharacterized LOC124431256, transcript variant X2
putative inorganic phosphate cotransporter
sperm flagellar protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sperm flagellar protein 1-like, transcript variant X1
U6 snRNA-associated Sm-like protein LSm3
ETS-related transcription factor Elf-5-like
ATP-binding cassette sub-family G member 1-like, transcript variant X1
ATP-binding cassette sub-family G member 1-like, transcript variant X4
ATP-binding cassette sub-family G member 1-like, transcript variant X3
ATP-binding cassette sub-family G member 1-like isoform X1
ATP-binding cassette sub-family G member 1-like isoform X3
ATP-binding cassette sub-family G member 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ATP-binding cassette sub-family G member 1-like isoform X2
lysine-specific demethylase 4A-like, transcript variant X2
lysine-specific demethylase 4A-like, transcript variant X1
lysine-specific demethylase 4A-like, transcript variant X3
lysine-specific demethylase 4A-like, transcript variant X4
lysine-specific demethylase 4A-like isoform X1
lysine-specific demethylase 4A-like isoform X3
lysine-specific demethylase 4A-like isoform X2
ATP-binding cassette sub-family G member 4, transcript variant X1
ATP-binding cassette sub-family G member 4, transcript variant X2
ATP-binding cassette sub-family G member 4, transcript variant X3
ATP-binding cassette sub-family G member 1 isoform X1
ATP-binding cassette sub-family G member 4 isoform X2
ATP-binding cassette sub-family G member 4
toll-like receptor 13, transcript variant X2
toll-like receptor 13, transcript variant X1
heparan sulfate 2-O-sulfotransferase pipe, transcript variant X2
heparan sulfate 2-O-sulfotransferase pipe, transcript variant X3
heparan sulfate 2-O-sulfotransferase pipe, transcript variant X1
heparan sulfate 2-O-sulfotransferase pipe isoform X1
heparan sulfate 2-O-sulfotransferase pipe isoform X2
heparan sulfate 2-O-sulfotransferase pipe isoform X3
glycogen-binding subunit 76A, transcript variant X8
glycogen-binding subunit 76A, transcript variant X3
glycogen-binding subunit 76A, transcript variant X6
glycogen-binding subunit 76A, transcript variant X5
glycogen-binding subunit 76A, transcript variant X1
glycogen-binding subunit 76A, transcript variant X10
glycogen-binding subunit 76A, transcript variant X4
glycogen-binding subunit 76A, transcript variant X2
glycogen-binding subunit 76A, transcript variant X7
glycogen-binding subunit 76A, transcript variant X9
divergent protein kinase domain 1C, transcript variant X1
divergent protein kinase domain 1C, transcript variant X2
divergent protein kinase domain 1C isoform X1
divergent protein kinase domain 1C isoform X2
divergent protein kinase domain 1C, transcript variant X3
divergent protein kinase domain 1C isoform X3
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tRNA:m(4)X modification enzyme TRM13 homolog isoform X1
tRNA:m(4)X modification enzyme TRM13 homolog isoform X2
hydroxysteroid dehydrogenase-like protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
putative helicase mov-10-B.1, transcript variant X1
putative helicase mov-10-B.1, transcript variant X2
putative helicase mov-10-B.1, transcript variant X3
putative helicase mov-10-B.1, transcript variant X5
putative helicase mov-10-B.1, transcript variant X4
uncharacterized LOC124431259, transcript variant X4
uncharacterized LOC124431259, transcript variant X3
uncharacterized LOC124431259, transcript variant X14
uncharacterized LOC124431259, transcript variant X1
uncharacterized LOC124431259, transcript variant X2
uncharacterized protein LOC124431259 isoform X1
uncharacterized protein LOC124431259 isoform X2
uncharacterized LOC124431259, transcript variant X10
uncharacterized LOC124431259, transcript variant X8
uncharacterized LOC124431259, transcript variant X6
uncharacterized LOC124431259, transcript variant X11
uncharacterized LOC124431259, transcript variant X12
uncharacterized LOC124431259, transcript variant X15
uncharacterized LOC124431259, transcript variant X5
uncharacterized LOC124431259, transcript variant X7
uncharacterized LOC124431259, transcript variant X9
uncharacterized LOC124431259, transcript variant X13
uncharacterized protein LOC124431259 isoform X3
uncharacterized protein LOC124431259 isoform X4
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
acyl-CoA synthetase short-chain family member 3, mitochondrial, transcript variant X2
acyl-CoA synthetase short-chain family member 3, mitochondrial, transcript variant X1
acyl-CoA synthetase short-chain family member 3, mitochondrial
acyl-CoA synthetase short-chain family member 3, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
inner nuclear membrane protein Man1, transcript variant X2
inner nuclear membrane protein Man1, transcript variant X1
inner nuclear membrane protein Man1 isoform X2
inner nuclear membrane protein Man1 isoform X1
inner nuclear membrane protein Man1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
inner nuclear membrane protein Man1 isoform X3
uncharacterized LOC124431112, transcript variant X9
uncharacterized LOC124431112, transcript variant X6
uncharacterized LOC124431112, transcript variant X8
uncharacterized LOC124431112, transcript variant X5
uncharacterized LOC124431112, transcript variant X7
uncharacterized LOC124431112, transcript variant X4
uncharacterized LOC124431112, transcript variant X3
uncharacterized LOC124431112, transcript variant X2
uncharacterized LOC124431112, transcript variant X1
uncharacterized LOC124431112, transcript variant X10
uncharacterized protein LOC124431112 isoform X4
uncharacterized protein LOC124431112 isoform X2
uncharacterized protein LOC124431112 isoform X1
uncharacterized protein LOC124431112 isoform X3
uncharacterized protein LOC124431112 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
mediator of RNA polymerase II transcription subunit 16, transcript variant X1
mediator of RNA polymerase II transcription subunit 16, transcript variant X2
mediator of RNA polymerase II transcription subunit 16 isoform X1
mediator of RNA polymerase II transcription subunit 16 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ATP-dependent zinc metalloprotease YME1L
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable methyltransferase-like protein 25
mediator of RNA polymerase II transcription subunit 8, transcript variant X1
mediator of RNA polymerase II transcription subunit 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 8 isoform X2
mediator of RNA polymerase II transcription subunit 8 isoform X1
odorant receptor 13a-like, transcript variant X1
odorant receptor 13a-like, transcript variant X3
odorant receptor 13a-like, transcript variant X2
uncharacterized protein LOC124430946 isoform X2
odorant receptor 13a-like, transcript variant X4
uncharacterized protein LOC124430946 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
aspartate--tRNA ligase, cytoplasmic, transcript variant X1
aspartate--tRNA ligase, cytoplasmic, transcript variant X2
aspartate--tRNA ligase, cytoplasmic isoform X1
aspartate--tRNA ligase, cytoplasmic isoform X2
hydroxymethylglutaryl-CoA lyase, mitochondrial
armadillo-like helical domain-containing protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
armadillo-like helical domain-containing protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
armadillo-like helical domain-containing protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
armadillo-like helical domain-containing protein 3 isoform X1
armadillo-like helical domain-containing protein 3 isoform X2
phosphatidylinositol 4-kinase type 2-alpha
stabilizer of axonemal microtubules 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X4
signal transducer and activator of transcription 5B, transcript variant X2
signal transducer and activator of transcription 5B, transcript variant X3
signal transducer and activator of transcription 5B, transcript variant X1
signal transducer and activator of transcription 5B, transcript variant X5
signal transducer and activator of transcription 5B, transcript variant X6
signal transducer and activator of transcription 5B isoform X1
signal transducer and activator of transcription 5B isoform X2
lysine-specific demethylase 8, transcript variant X4
lysine-specific demethylase 8, transcript variant X3
UDP-N-acetylglucosamine transferase subunit ALG14 homolog
lysine-specific demethylase 8, transcript variant X5
lysine-specific demethylase 8, transcript variant X1
lysine-specific demethylase 8, transcript variant X2
lysine-specific demethylase 8 isoform X1
lysine-specific demethylase 8 isoform X2
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X3
probable serine/threonine-protein kinase DDB_G0282963
alkylglycerol monooxygenase-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
alkylglycerol monooxygenase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
alkylglycerol monooxygenase-like, transcript variant X2
alkylglycerol monooxygenase-like, transcript variant X1
alkylglycerol monooxygenase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
alkylglycerol monooxygenase-like isoform X3
alkylglycerol monooxygenase-like isoform X1
alkylglycerol monooxygenase-like isoform X2
uncharacterized LOC124431193, transcript variant X1
uncharacterized LOC124431193, transcript variant X2
uncharacterized LOC124431193, transcript variant X3
lysosomal alpha-mannosidase, transcript variant X1
lysosomal alpha-mannosidase, transcript variant X2
uncharacterized LOC124431189, transcript variant X2
uncharacterized LOC124431189, transcript variant X1
uncharacterized protein LOC124431189 isoform X1
uncharacterized protein LOC124431189 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
probable Rho GTPase-activating protein CG5521, transcript variant X4
probable Rho GTPase-activating protein CG5521, transcript variant X7
probable Rho GTPase-activating protein CG5521, transcript variant X5
probable Rho GTPase-activating protein CG5521, transcript variant X2
probable Rho GTPase-activating protein CG5521, transcript variant X1
probable Rho GTPase-activating protein CG5521, transcript variant X3
ral GTPase-activating protein subunit alpha-1 isoform X2
probable Rho GTPase-activating protein CG5521 isoform X5
ral GTPase-activating protein subunit alpha-1 isoform X3
ral GTPase-activating protein subunit alpha-1 isoform X1
probable Rho GTPase-activating protein CG5521, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ral GTPase-activating protein subunit alpha-1 isoform X4
homeobox protein SIX2-like, transcript variant X2
homeobox protein SIX2-like, transcript variant X4
homeobox protein SIX2-like, transcript variant X1
homeobox protein SIX2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative uncharacterized protein DDB_G0282129, transcript variant X1
putative uncharacterized protein DDB_G0282129, transcript variant X2
putative uncharacterized protein DDB_G0282129, transcript variant X5
putative uncharacterized protein DDB_G0282129, transcript variant X4
putative uncharacterized protein DDB_G0282129, transcript variant X3
putative mediator of RNA polymerase II transcription subunit 26 isoform X1
putative uncharacterized protein DDB_G0282129 isoform X2
uncharacterized LOC124431173, transcript variant X2
uncharacterized LOC124431173, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proline hydroxylase buaE-like, transcript variant X1
proline hydroxylase buaE-like, transcript variant X2
translation initiation factor IF-2, mitochondrial, transcript variant X1
translation initiation factor IF-2, mitochondrial, transcript variant X2
translation initiation factor IF-2, mitochondrial isoform X1
translation initiation factor IF-2, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 245, transcript variant X2
transmembrane protein 245, transcript variant X1
cilia- and flagella-associated protein 97-like
multiple RNA-binding domain-containing protein 1-like, transcript variant X2
multiple RNA-binding domain-containing protein 1-like, transcript variant X1
multiple RNA-binding domain-containing protein 1-like, transcript variant X3
multiple RNA-binding domain-containing protein 1-like
uncharacterized LOC124430971, transcript variant X1
uncharacterized LOC124430971, transcript variant X2
uncharacterized protein LOC124430971 isoform X1
uncharacterized protein LOC124430971 isoform X2
3'-5' ssDNA/RNA exonuclease TatD, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
3'-5' ssDNA/RNA exonuclease TatD, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
3'-5' ssDNA/RNA exonuclease TatD, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
3'-5' ssDNA/RNA exonuclease TatD, transcript variant X2
3'-5' ssDNA/RNA exonuclease TatD, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
proteasome activator complex subunit 4B-like, transcript variant X1
proteasome activator complex subunit 4B-like, transcript variant X2
proteasome activator complex subunit 4B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
homeobox protein 3-like, transcript variant X2
homeobox protein 3-like, transcript variant X1
uncharacterized LOC124431272, transcript variant X1
uncharacterized LOC124431272, transcript variant X2
uncharacterized protein LOC124431272 isoform X1
uncharacterized protein LOC124431272 isoform X2
adipocyte plasma membrane-associated protein-like
uncharacterized LOC124431270, transcript variant X1
uncharacterized LOC124431270, transcript variant X2
uncharacterized protein LOC124431270 isoform X1
uncharacterized protein LOC124431270 isoform X2
RNA helicase aquarius, transcript variant X1
RNA helicase aquarius, transcript variant X2
RNA helicase aquarius, transcript variant X3
G-protein coupled receptor Mth2-like, transcript variant X3
G-protein coupled receptor Mth2-like, transcript variant X2
G-protein coupled receptor Mth2-like, transcript variant X1
G-protein coupled receptor Mth2-like isoform X1
G-protein coupled receptor Mth2-like isoform X2
probable G-protein coupled receptor Mth-like 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
single-strand selective monofunctional uracil DNA glycosylase
probable tubulin polyglutamylase ttll-15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
probable tubulin polyglutamylase ttll-15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable tubulin polyglutamylase ttll-15 isoform X2
probable tubulin polyglutamylase ttll-15 isoform X1
transmembrane protein 256-like, transcript variant X2
transmembrane protein 256-like, transcript variant X1
transmembrane protein 256-like isoform X1
transmembrane protein 256-like isoform X2
E3 ubiquitin-protein ligase TRIP12, transcript variant X4
E3 ubiquitin-protein ligase TRIP12, transcript variant X6
E3 ubiquitin-protein ligase TRIP12, transcript variant X5
E3 ubiquitin-protein ligase TRIP12, transcript variant X8
E3 ubiquitin-protein ligase TRIP12, transcript variant X7
E3 ubiquitin-protein ligase TRIP12, transcript variant X2
E3 ubiquitin-protein ligase TRIP12, transcript variant X11
E3 ubiquitin-protein ligase TRIP12, transcript variant X3
E3 ubiquitin-protein ligase TRIP12, transcript variant X1
E3 ubiquitin-protein ligase TRIP12, transcript variant X9
E3 ubiquitin-protein ligase TRIP12, transcript variant X10
E3 ubiquitin-protein ligase TRIP12 isoform X4
E3 ubiquitin-protein ligase TRIP12 isoform X3
E3 ubiquitin-protein ligase TRIP12 isoform X5
E3 ubiquitin-protein ligase TRIP12 isoform X2
E3 ubiquitin-protein ligase TRIP12 isoform X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial
membrane-bound transcription factor site-1 protease, transcript variant X2
membrane-bound transcription factor site-1 protease, transcript variant X1
membrane-bound transcription factor site-1 protease, transcript variant X3
membrane-bound transcription factor site-1 protease isoform X2
membrane-bound transcription factor site-1 protease isoform X1
membrane-bound transcription factor site-1 protease isoform X3
general transcription factor 3C polypeptide 3, transcript variant X3
general transcription factor 3C polypeptide 3, transcript variant X2
general transcription factor 3C polypeptide 3, transcript variant X1
general transcription factor 3C polypeptide 3
uncharacterized LOC124431050, transcript variant X2
uncharacterized LOC124431050, transcript variant X3
uncharacterized LOC124431050, transcript variant X1
uncharacterized LOC124431050, transcript variant X6
uncharacterized LOC124431050, transcript variant X4
uncharacterized LOC124431050, transcript variant X5
uncharacterized LOC124431050, transcript variant X8
uncharacterized LOC124431050, transcript variant X7
uncharacterized LOC124431050, transcript variant X9
uncharacterized protein LOC124431050 isoform X2
uncharacterized protein LOC124431050 isoform X1
uncharacterized protein LOC124431050 isoform X3
uncharacterized protein LOC124431050 isoform X4
uncharacterized protein LOC124431050 isoform X5
uncharacterized protein LOC124431050 isoform X6
doublesex- and mab-3-related transcription factor A2-like
leucine-rich repeat-containing protein 49, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine-rich repeat-containing protein 49, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
leucine-rich repeat-containing protein 49, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine-rich repeat-containing protein 49 isoform X3
leucine-rich repeat-containing protein 49 isoform X2
leucine-rich repeat-containing protein 49 isoform X1
39S ribosomal protein L54, mitochondrial
uncharacterized LOC124431122, transcript variant X1
uncharacterized LOC124431122, transcript variant X2
nuclear fragile X mental retardation-interacting protein 1, transcript variant X1
nuclear fragile X mental retardation-interacting protein 1, transcript variant X2
nuclear fragile X mental retardation-interacting protein 1
tight junction protein ZO-2, transcript variant X2
tight junction protein ZO-2, transcript variant X4
tight junction protein ZO-2, transcript variant X1
tight junction protein ZO-2, transcript variant X3
tight junction protein ZO-2, transcript variant X6
tight junction protein ZO-2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
facilitated trehalose transporter Tret1-2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromatin-remodeling complex ATPase chain Iswi-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
chromatin-remodeling complex ATPase chain Iswi-like isoform X1
chromatin-remodeling complex ATPase chain Iswi-like, transcript variant X3
chromatin-remodeling complex ATPase chain Iswi-like, transcript variant X7
chromatin-remodeling complex ATPase chain Iswi-like, transcript variant X8
chromatin-remodeling complex ATPase chain Iswi-like, transcript variant X5
chromatin-remodeling complex ATPase chain Iswi-like, transcript variant X2
chromatin-remodeling complex ATPase chain Iswi-like, transcript variant X4
chromatin-remodeling complex ATPase chain Iswi-like, transcript variant X6
uncharacterized LOC124430964, transcript variant X1
uncharacterized LOC124430964, transcript variant X2
uncharacterized LOC124430964, transcript variant X3
ubiquitin-protein ligase E3A, transcript variant X6
ubiquitin-protein ligase E3A, transcript variant X1
ubiquitin-protein ligase E3A, transcript variant X4
ubiquitin-protein ligase E3A, transcript variant X3
ubiquitin-protein ligase E3A, transcript variant X2
ubiquitin-protein ligase E3A, transcript variant X5
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X2
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X3
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X4
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X1
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X5
sodium- and chloride-dependent glycine transporter 1-like
transmembrane reductase CYB561D2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transmembrane reductase CYB561D2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane reductase CYB561D2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
eye-specific diacylglycerol kinase, transcript variant X2
eye-specific diacylglycerol kinase isoform X2
eye-specific diacylglycerol kinase, transcript variant X1
eye-specific diacylglycerol kinase isoform X1
uncharacterized LOC124431055, transcript variant X1
uncharacterized LOC124431055, transcript variant X2
uncharacterized LOC124431055, transcript variant X3
troponin T, skeletal muscle, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
troponin T, skeletal muscle, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
troponin T, skeletal muscle, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
troponin T, skeletal muscle, transcript variant X4
troponin T, skeletal muscle, transcript variant X3
troponin T, skeletal muscle, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
troponin T, skeletal muscle, transcript variant X5
troponin T, skeletal muscle, transcript variant X8
U11/U12 small nuclear ribonucleoprotein 35 kDa protein-like
probable serine/threonine-protein kinase fhkE, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
probable serine/threonine-protein kinase fhkE, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
probable serine/threonine-protein kinase fhkE, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable serine/threonine-protein kinase fhkE, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
probable serine/threonine-protein kinase fhkE, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
probable serine/threonine-protein kinase fhkE isoform X1
probable serine/threonine-protein kinase fhkE isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124431062, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC124431062, transcript variant X4
uncharacterized LOC124431062, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC124431062, transcript variant X1
uncharacterized protein LOC124431062 isoform X1
uncharacterized protein LOC124431062 isoform X2
NADH-cytochrome b5 reductase 3, transcript variant X3
NADH-cytochrome b5 reductase 3, transcript variant X1
NADH-cytochrome b5 reductase 3 isoform X3
NADH-cytochrome b5 reductase 3 isoform X1
NADH-cytochrome b5 reductase 3, transcript variant X4
NADH-cytochrome b5 reductase 3, transcript variant X5
NADH-cytochrome b5 reductase 3, transcript variant X2
NADH-cytochrome b5 reductase 3 isoform X2
NADH-cytochrome b5 reductase 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fork head domain transcription factor slp1-like
methyltransferase-like protein 7A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
methyltransferase-like protein 7A, transcript variant X1
protein PF14_0175-like, transcript variant X3
protein PF14_0175-like, transcript variant X2
protein PF14_0175-like, transcript variant X1
structural maintenance of chromosomes protein 1A
fibril-forming collagen alpha chain-like
presenilin homolog, transcript variant X2
presenilin homolog, transcript variant X5
presenilin homolog, transcript variant X1
presenilin homolog, transcript variant X4
presenilin homolog, transcript variant X3
kinesin-like protein Klp98A, transcript variant X2
kinesin-like protein Klp98A, transcript variant X1
kinesin-like protein Klp98A, transcript variant X3
unconventional myosin heavy chain 6 isoform X2
unconventional myosin heavy chain 6 isoform X3
calcium-independent protein kinase C isoform X4
uncharacterized protein ZC84.1, transcript variant X4
uncharacterized protein ZC84.1 isoform X2
uncharacterized protein ZC84.1, transcript variant X2
uncharacterized protein ZC84.1, transcript variant X3
uncharacterized protein ZC84.1, transcript variant X1
uncharacterized protein ZC84.1 isoform X1
probable ATP-dependent RNA helicase DDX17, transcript variant X2
probable ATP-dependent RNA helicase DDX17, transcript variant X1
probable ATP-dependent RNA helicase DDX17 isoform X2
probable ATP-dependent RNA helicase DDX17 isoform X1
probable ATP-dependent RNA helicase DDX43
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
B-box type zinc finger protein ncl-1-like, transcript variant X1
B-box type zinc finger protein ncl-1-like, transcript variant X2
B-box type zinc finger protein ncl-1-like isoform X2
B-box type zinc finger protein ncl-1-like isoform X1
zinc finger protein 300-like, transcript variant X2
zinc finger protein 300-like, transcript variant X1
zinc finger protein 300-like, transcript variant X3
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, transcript variant X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, transcript variant X3
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, transcript variant X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B isoform X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B isoform X3
uncharacterized LOC124431220, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC124431220, transcript variant X2
uncharacterized protein LOC124431220 isoform X2
uncharacterized protein LOC124431220 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ornithine aminotransferase, mitochondrial-like
ornithine aminotransferase, mitochondrial-like, transcript variant X3
ornithine aminotransferase, mitochondrial-like, transcript variant X4
ornithine aminotransferase, mitochondrial-like, transcript variant X1
ornithine aminotransferase, mitochondrial-like, transcript variant X2
cell division cycle-associated protein 7-like
uncharacterized LOC124431228, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124431228, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC124431228, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
SWI/SNF complex subunit SMARCC2, transcript variant X2
SWI/SNF complex subunit SMARCC2 isoform X2
SWI/SNF complex subunit SMARCC2, transcript variant X1
SWI/SNF complex subunit SMARCC2, transcript variant X3
SWI/SNF complex subunit SMARCC2 isoform X1
SWI/SNF complex subunit SMARCC2 isoform X3
SWI/SNF complex subunit SMARCC2, transcript variant X5
SWI/SNF complex subunit SMARCC2, transcript variant X4
SWI/SNF complex subunit SMARCC2 isoform X4
SWI/SNF complex subunit SMARCC2 isoform X5
uncharacterized LOC124431229, transcript variant X9
uncharacterized LOC124431229, transcript variant X3
uncharacterized LOC124431229, transcript variant X2
uncharacterized LOC124431229, transcript variant X7
uncharacterized LOC124431229, transcript variant X4
uncharacterized LOC124431229, transcript variant X1
uncharacterized LOC124431229, transcript variant X8
uncharacterized LOC124431229, transcript variant X5
uncharacterized LOC124431229, transcript variant X12
uncharacterized LOC124431229, transcript variant X13
uncharacterized LOC124431229, transcript variant X6
uncharacterized LOC124431229, transcript variant X11
uncharacterized LOC124431229, transcript variant X10
major facilitator superfamily domain-containing protein 10, transcript variant X5
major facilitator superfamily domain-containing protein 10, transcript variant X8
major facilitator superfamily domain-containing protein 10, transcript variant X2
major facilitator superfamily domain-containing protein 10, transcript variant X4
major facilitator superfamily domain-containing protein 10 isoform X2
major facilitator superfamily domain-containing protein 10 isoform X4
major facilitator superfamily domain-containing protein 10, transcript variant X3
major facilitator superfamily domain-containing protein 10, transcript variant X6
major facilitator superfamily domain-containing protein 10, transcript variant X9
major facilitator superfamily domain-containing protein 10 isoform X3
major facilitator superfamily domain-containing protein 10 isoform X6
major facilitator superfamily domain-containing protein 10 isoform X9
major facilitator superfamily domain-containing protein 10, transcript variant X7
major facilitator superfamily domain-containing protein 10, transcript variant X10
major facilitator superfamily domain-containing protein 10, transcript variant X1
major facilitator superfamily domain-containing protein 10 isoform X1
major facilitator superfamily domain-containing protein 10 isoform X10
major facilitator superfamily domain-containing protein 10 isoform X7
major facilitator superfamily domain-containing protein 10 isoform X5
major facilitator superfamily domain-containing protein 10 isoform X8
putative thiamine transporter SLC35F3, transcript variant X3
putative thiamine transporter SLC35F3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
putative thiamine transporter SLC35F3, transcript variant X7
putative thiamine transporter SLC35F3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
putative thiamine transporter SLC35F3, transcript variant X2
putative thiamine transporter SLC35F3, transcript variant X1
putative thiamine transporter SLC35F3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
putative thiamine transporter SLC35F3, transcript variant X12
putative thiamine transporter SLC35F3, transcript variant X9
putative thiamine transporter SLC35F3, transcript variant X10
putative thiamine transporter SLC35F3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
putative thiamine transporter SLC35F3, transcript variant X13
putative thiamine transporter SLC35F3 isoform X4
putative thiamine transporter SLC35F3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
putative thiamine transporter SLC35F3 isoform X5
putative thiamine transporter SLC35F3 isoform X6
putative thiamine transporter SLC35F3 isoform X8
putative thiamine transporter SLC35F3 isoform X1
putative thiamine transporter SLC35F3 isoform X3
putative thiamine transporter SLC35F3 isoform X7
putative thiamine transporter SLC35F3 isoform X9
putative thiamine transporter SLC35F3 isoform X2
glutathione S-transferase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutathione S-transferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glutathione S-transferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
kinetochore-associated protein 1, transcript variant X2
kinetochore-associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
kinetochore-associated protein 1 isoform X1
kinetochore-associated protein 1 isoform X2
uncharacterized LOC124431286, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC124431286, transcript variant X1
uncharacterized LOC124431286, transcript variant X2
serine protease gd-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
serine protease gd-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PAX-interacting protein 1-like, transcript variant X2
PAX-interacting protein 1-like, transcript variant X1
PAX-interacting protein 1-like, transcript variant X4
PAX-interacting protein 1-like, transcript variant X3
PAX-interacting protein 1-like isoform X2
PAX-interacting protein 1-like isoform X1
PAX-interacting protein 1-like isoform X3
Meckel syndrome type 1 protein-like, transcript variant X2
Meckel syndrome type 1 protein-like, transcript variant X1
Meckel syndrome type 1 protein-like isoform X2
Meckel syndrome type 1 protein-like isoform X1
rhomboid-related protein 2, transcript variant X2
rhomboid-related protein 2, transcript variant X1
protein split ends, transcript variant X6
protein split ends, transcript variant X3
protein split ends, transcript variant X4
protein split ends, transcript variant X5
protein split ends, transcript variant X1
protein split ends, transcript variant X7
protein split ends, transcript variant X2
protein split ends, transcript variant X8
protein split ends, transcript variant X9
uncharacterized protein LOC124430997 isoform X3
39S ribosomal protein L44, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
39S ribosomal protein L44, mitochondrial, transcript variant X2
39S ribosomal protein L44, mitochondrial, transcript variant X1
39S ribosomal protein L44, mitochondrial
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00535
clathrin heavy chain, transcript variant X1
clathrin heavy chain, transcript variant X2
microprocessor complex subunit DGCR8, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microprocessor complex subunit DGCR8, transcript variant X8
microprocessor complex subunit DGCR8, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
microprocessor complex subunit DGCR8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
microprocessor complex subunit DGCR8, transcript variant X4
microprocessor complex subunit DGCR8, transcript variant X3
microprocessor complex subunit DGCR8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
microprocessor complex subunit DGCR8, transcript variant X7
microprocessor complex subunit DGCR8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
microprocessor complex subunit DGCR8, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
microprocessor complex subunit DGCR8 isoform X1
microprocessor complex subunit DGCR8 isoform X2
serine/threonine-protein kinase Tao, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
serine/threonine-protein kinase Tao, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
serine/threonine-protein kinase Tao, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 6, transcript variant X1
cleavage and polyadenylation specificity factor subunit 6, transcript variant X5
cleavage and polyadenylation specificity factor subunit 6, transcript variant X7
cleavage and polyadenylation specificity factor subunit 6, transcript variant X3
cleavage and polyadenylation specificity factor subunit 6, transcript variant X6
vacuolar protein sorting-associated protein 33A
cleavage and polyadenylation specificity factor subunit 6, transcript variant X2
cleavage and polyadenylation specificity factor subunit 6, transcript variant X4
cleavage and polyadenylation specificity factor subunit 6 isoform X1
cleavage and polyadenylation specificity factor subunit 6 isoform X2
cleavage and polyadenylation specificity factor subunit 6 isoform X4
cleavage and polyadenylation specificity factor subunit 6 isoform X5
cleavage and polyadenylation specificity factor subunit 6 isoform X6
cleavage and polyadenylation specificity factor subunit 6 isoform X3
Hermansky-Pudlak syndrome 5 protein homolog
meiotic nuclear division protein 1 homolog, transcript variant X1
meiotic nuclear division protein 1 homolog, transcript variant X2
meiotic nuclear division protein 1 homolog
squamous cell carcinoma antigen recognized by T-cells 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
integral membrane protein 2A, transcript variant X2
integral membrane protein 2A, transcript variant X1
general transcriptional corepressor trfA-like
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
calcium uptake protein 3, mitochondrial, transcript variant X2
calcium uptake protein 3, mitochondrial, transcript variant X1
calcium uptake protein 3, mitochondrial, transcript variant X5
calcium uptake protein 3, mitochondrial, transcript variant X3
calcium uptake protein 3, mitochondrial, transcript variant X4
calcium uptake protein 3, mitochondrial isoform X1
calcium uptake protein 3, mitochondrial isoform X3
calcium uptake protein 3, mitochondrial isoform X4
calcium uptake protein 3, mitochondrial isoform X2
calcium uptake protein 3, mitochondrial isoform X5
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124430982, transcript variant X2
uncharacterized LOC124430982, transcript variant X3
uncharacterized LOC124430982, transcript variant X1
uncharacterized protein LOC124430982 isoform X1
uncharacterized protein LOC124430982 isoform X2
uncharacterized protein LOC124430982 isoform X3
distal membrane-arm assembly complex protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
U11/U12 small nuclear ribonucleoprotein 25 kDa protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein C14orf119, transcript variant X4
uncharacterized protein C14orf119, transcript variant X3
uncharacterized protein C14orf119, transcript variant X1
uncharacterized protein C14orf119, transcript variant X2
uncharacterized protein C14orf119, transcript variant X5
uncharacterized protein C14orf119, transcript variant X7
uncharacterized protein C14orf119, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RNA-binding protein 28-like, transcript variant X1
RNA-binding protein 28-like, transcript variant X2
probable cytochrome P450 301a1, mitochondrial
transmembrane protein 120 homolog, transcript variant X1
transmembrane protein 120 homolog, transcript variant X2
transmembrane protein 120 homolog isoform X1
transmembrane protein 120 homolog isoform X2
cytochrome P450 315a1, mitochondrial, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome P450 315a1, mitochondrial isoform X2
cytochrome P450 315a1, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytochrome P450 315a1, mitochondrial, transcript variant X1
cytochrome P450 315a1, mitochondrial, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytochrome P450 315a1, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytochrome P450 315a1, mitochondrial isoform X1
cytochrome P450 315a1, mitochondrial isoform X3
active breakpoint cluster region-related protein, transcript variant X2
active breakpoint cluster region-related protein, transcript variant X1
active breakpoint cluster region-related protein, transcript variant X3
active breakpoint cluster region-related protein isoform X1
active breakpoint cluster region-related protein isoform X2
tyramine beta-hydroxylase, transcript variant X2
tyramine beta-hydroxylase, transcript variant X1
putative phospholipase B-like lamina ancestor, transcript variant X1
putative phospholipase B-like lamina ancestor, transcript variant X2
putative phospholipase B-like lamina ancestor
BUB3-interacting and GLEBS motif-containing protein ZNF207, transcript variant X2
BUB3-interacting and GLEBS motif-containing protein ZNF207, transcript variant X3
BUB3-interacting and GLEBS motif-containing protein ZNF207, transcript variant X1
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X1
BUB3-interacting and GLEBS motif-containing protein ZNF207, transcript variant X4
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X2
BUB3-interacting and GLEBS motif-containing protein ZNF207, transcript variant X5
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 30 homolog, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 30 homolog, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 30 homolog isoform X1
ubiquitin carboxyl-terminal hydrolase 30 isoform X2
proteoglycan 4-like, transcript variant X1
proteoglycan 4-like, transcript variant X3
proteoglycan 4-like, transcript variant X2
proteoglycan 4-like, transcript variant X7
proteoglycan 4-like, transcript variant X4
proteoglycan 4-like, transcript variant X6
proteoglycan 4-like, transcript variant X12
proteoglycan 4-like, transcript variant X5
proteoglycan 4-like, transcript variant X15
proteoglycan 4-like, transcript variant X17
proteoglycan 4-like, transcript variant X8
proteoglycan 4-like, transcript variant X9
proteoglycan 4-like, transcript variant X11
proteoglycan 4-like, transcript variant X20
proteoglycan 4-like, transcript variant X14
proteoglycan 4-like, transcript variant X19
proteoglycan 4-like, transcript variant X13
proteoglycan 4-like, transcript variant X16
proteoglycan 4-like, transcript variant X10
proteoglycan 4-like, transcript variant X24
proteoglycan 4-like, transcript variant X22
proteoglycan 4-like, transcript variant X18
proteoglycan 4-like, transcript variant X23
proteoglycan 4-like, transcript variant X25
proteoglycan 4-like, transcript variant X21
proteoglycan 4-like, transcript variant X26
uncharacterized protein LOC124430966 isoform X12
uncharacterized protein LOC124430966 isoform X7
uncharacterized protein LOC124430966 isoform X8
uncharacterized protein LOC124430966 isoform X3
uncharacterized protein LOC124430966 isoform X10
uncharacterized protein LOC124430966 isoform X5
uncharacterized protein LOC124430966 isoform X24
uncharacterized protein LOC124430966 isoform X21
uncharacterized protein LOC124430966 isoform X9
uncharacterized protein LOC124430966 isoform X23
uncharacterized protein LOC124430966 isoform X18
uncharacterized protein LOC124430966 isoform X14
zinc finger HIT domain-containing protein 3
matrix metalloproteinase-2, transcript variant X2
matrix metalloproteinase-2, transcript variant X1
matrix metalloproteinase-2, transcript variant X3
matrix metalloproteinase-2, transcript variant X4
phosphopantothenoylcysteine decarboxylase
cytochrome c oxidase assembly protein COX19
tRNA (guanine(10)-N2)-methyltransferase homolog, transcript variant X2
tRNA (guanine(10)-N2)-methyltransferase homolog, transcript variant X1
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X1
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X2
ER membrane protein complex subunit 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cleavage and polyadenylation specificity factor 73, transcript variant X1
cleavage and polyadenylation specificity factor 73 isoform X1
cleavage and polyadenylation specificity factor 73, transcript variant X2
cleavage and polyadenylation specificity factor 73, transcript variant X3
cleavage and polyadenylation specificity factor 73 isoform X2
mitochondrial Rho GTPase, transcript variant X1
mitochondrial Rho GTPase, transcript variant X2
mitochondrial Rho GTPase, transcript variant X3
coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial-like
coiled-coil-helix-coiled-coil-helix domain-containing protein 2, transcript variant X2
coiled-coil-helix-coiled-coil-helix domain-containing protein 2, transcript variant X3
coiled-coil-helix-coiled-coil-helix domain-containing protein 2, transcript variant X1
coiled-coil-helix-coiled-coil-helix domain-containing protein 2
transducin beta-like protein 2, transcript variant X7
transducin beta-like protein 2, transcript variant X8
transducin beta-like protein 2, transcript variant X1
transducin beta-like protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transducin beta-like protein 2 isoform X4
transducin beta-like protein 2 isoform X5
putative uncharacterized protein DDB_G0289263 isoform X1
putative uncharacterized protein DDB_G0289263 isoform X2
transducin beta-like protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transducin beta-like protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transducin beta-like protein 2, transcript variant X4
transducin beta-like protein 2, transcript variant X5
putative uncharacterized protein DDB_G0289263 isoform X3
RNA-binding protein cabeza-like, transcript variant X2
RNA-binding protein cabeza-like, transcript variant X1
RNA-binding protein cabeza-like, transcript variant X3
RNA-binding protein cabeza-like isoform X2
RNA-binding protein cabeza-like isoform X1
RNA-binding protein cabeza-like isoform X3
mediator of RNA polymerase II transcription subunit 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
palmitoyltransferase ZDHHC8, transcript variant X1
palmitoyltransferase ZDHHC8, transcript variant X2
RNA-binding protein with serine-rich domain 1-like
autism susceptibility gene 2 protein, transcript variant X3
autism susceptibility gene 2 protein, transcript variant X5
autism susceptibility gene 2 protein, transcript variant X2
autism susceptibility gene 2 protein, transcript variant X4
autism susceptibility gene 2 protein, transcript variant X1
autism susceptibility gene 2 protein, transcript variant X6
autism susceptibility gene 2 protein, transcript variant X8
autism susceptibility gene 2 protein, transcript variant X7
autism susceptibility gene 2 protein isoform X2
autism susceptibility gene 2 protein isoform X4
autism susceptibility gene 2 protein isoform X3
autism susceptibility gene 2 protein isoform X1
autism susceptibility gene 2 protein isoform X5
autism susceptibility gene 2 protein isoform X7
autism susceptibility gene 2 protein isoform X6
uncharacterized LOC124431199, transcript variant X1
uncharacterized LOC124431199, transcript variant X6
uncharacterized LOC124431199, transcript variant X7
uncharacterized LOC124431199, transcript variant X8
uncharacterized LOC124431199, transcript variant X10
uncharacterized LOC124431199, transcript variant X9
uncharacterized LOC124431199, transcript variant X2
uncharacterized LOC124431199, transcript variant X4
uncharacterized LOC124431199, transcript variant X3
uncharacterized LOC124431199, transcript variant X5
uncharacterized protein LOC124431199 isoform X1
uncharacterized protein LOC124431199 isoform X2
uncharacterized protein LOC124431199 isoform X3
uncharacterized protein LOC124431199 isoform X4
uncharacterized protein LOC124431199 isoform X5
uncharacterized protein LOC124431199 isoform X6
vitamin K epoxide reductase complex subunit 1-like protein 1
SUMO-conjugating enzyme UBC9-B, transcript variant X1
SUMO-conjugating enzyme UBC9-B, transcript variant X2
protein singed wings 2, transcript variant X2
protein singed wings 2, transcript variant X1
uncharacterized LOC124431276, transcript variant X1
uncharacterized LOC124431276, transcript variant X2
uncharacterized protein LOC124431276 isoform X2
uncharacterized protein LOC124431276 isoform X1
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X1
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X2
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X1
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X2
TAR DNA-binding protein 43-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
TAR DNA-binding protein 43-like, transcript variant X3
TAR DNA-binding protein 43-like, transcript variant X1
TAR DNA-binding protein 43-like isoform X1
TAR DNA-binding protein 43-like isoform X3
uncharacterized protein LOC124431274 isoform X2
TAR DNA-binding protein 43-like, transcript variant X4
TAR DNA-binding protein 43-like isoform X4
phenoloxidase-activating factor 2, transcript variant X2
phenoloxidase-activating factor 2, transcript variant X1
phenoloxidase-activating factor 2 isoform X2
phenoloxidase-activating factor 2 isoform X1
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
CLIP domain-containing serine protease B8-like, transcript variant X1
CLIP domain-containing serine protease B8-like, transcript variant X3
CLIP domain-containing serine protease B8-like, transcript variant X2
CLIP domain-containing serine protease B8-like, transcript variant X4
CLIP domain-containing serine protease B8-like, transcript variant X5
uncharacterized protein LOC124431066 isoform X1
uncharacterized protein LOC124431066 isoform X2
CLIP domain-containing serine protease B8-like isoform X4
protein tramtrack, alpha isoform-like, transcript variant X3
protein tramtrack, alpha isoform-like, transcript variant X5
protein tramtrack, alpha isoform-like, transcript variant X9
protein tramtrack, alpha isoform-like, transcript variant X6
protein tramtrack, alpha isoform-like, transcript variant X7
protein tramtrack, alpha isoform-like, transcript variant X8
protein tramtrack, alpha isoform-like, transcript variant X2
protein tramtrack, alpha isoform-like, transcript variant X4
protein tramtrack, alpha isoform-like, transcript variant X15
protein tramtrack, alpha isoform-like, transcript variant X1
protein tramtrack, alpha isoform-like, transcript variant X12
protein tramtrack, alpha isoform-like, transcript variant X11
protein tramtrack, alpha isoform-like, transcript variant X10
protein tramtrack, alpha isoform-like, transcript variant X13
protein tramtrack, alpha isoform-like, transcript variant X16
protein tramtrack, alpha isoform-like, transcript variant X14
protein tramtrack, alpha isoform-like isoform X1
protein tramtrack, alpha isoform-like isoform X2
protein tramtrack, alpha isoform-like isoform X3
conserved oligomeric Golgi complex subunit 7, transcript variant X1
conserved oligomeric Golgi complex subunit 7, transcript variant X2
conserved oligomeric Golgi complex subunit 7 isoform X1
conserved oligomeric Golgi complex subunit 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
condensin-2 complex subunit G2-like, transcript variant X1
condensin-2 complex subunit G2-like, transcript variant X2
condensin-2 complex subunit G2-like, transcript variant X5
condensin-2 complex subunit G2-like, transcript variant X4
condensin-2 complex subunit G2-like isoform X2
condensin-2 complex subunit G2-like isoform X1
condensin-2 complex subunit G2-like isoform X5
condensin-2 complex subunit G2-like isoform X4
condensin-2 complex subunit G2-like, transcript variant X3
condensin-2 complex subunit G2-like isoform X3
condensin-2 complex subunit G2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
condensin-2 complex subunit G2-like isoform X6
uncharacterized protein T19C3.4-like, transcript variant X7
uncharacterized protein T19C3.4-like, transcript variant X2
uncharacterized protein T19C3.4-like, transcript variant X3
uncharacterized protein T19C3.4-like, transcript variant X4
uncharacterized protein T19C3.4-like, transcript variant X1
uncharacterized protein T19C3.4-like, transcript variant X5
uncharacterized protein T19C3.4-like isoform X6
receptor expression-enhancing protein 4-like isoform X3
receptor expression-enhancing protein 4-like isoform X2
receptor expression-enhancing protein 4-like isoform X1
uncharacterized protein T19C3.4-like isoform X4
uncharacterized protein T19C3.4-like, transcript variant X6
receptor expression-enhancing protein 4-like isoform X5
uncharacterized LOC124431148, transcript variant X1
uncharacterized LOC124431148, transcript variant X8
uncharacterized LOC124431148, transcript variant X7
uncharacterized LOC124431148, transcript variant X9
uncharacterized LOC124431148, transcript variant X6
uncharacterized LOC124431148, transcript variant X2
uncharacterized LOC124431148, transcript variant X3
uncharacterized LOC124431148, transcript variant X4
uncharacterized LOC124431148, transcript variant X5
uncharacterized protein LOC124431148 isoform X1
uncharacterized protein LOC124431148 isoform X4
uncharacterized protein LOC124431148 isoform X3
uncharacterized protein LOC124431148 isoform X5
uncharacterized protein LOC124431148 isoform X2
uncharacterized LOC124431148, transcript variant X10
uncharacterized protein LOC124431148 isoform X6
uncharacterized LOC124431162, transcript variant X2
uncharacterized LOC124431162, transcript variant X1
set1/Ash2 histone methyltransferase complex subunit ASH2
dimethyladenosine transferase 2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
autophagy-related protein 2 homolog A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
autophagy-related protein 2 homolog A, transcript variant X2
autophagy-related protein 2 homolog A, transcript variant X1
autophagy-related protein 2 homolog A isoform X1
autophagy-related protein 2 homolog A isoform X2
autophagy-related protein 2 homolog B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
FERM domain-containing protein 8, transcript variant X4
FERM domain-containing protein 8, transcript variant X5
FERM domain-containing protein 8, transcript variant X1
FERM domain-containing protein 8, transcript variant X2
FERM domain-containing protein 8, transcript variant X3
phospholipid-transporting ATPase ID, transcript variant X2
phospholipid-transporting ATPase ID, transcript variant X8
phospholipid-transporting ATPase ID, transcript variant X7
phospholipid-transporting ATPase ID, transcript variant X4
phospholipid-transporting ATPase ID, transcript variant X9
phospholipid-transporting ATPase ID, transcript variant X11
phospholipid-transporting ATPase ID, transcript variant X10
phospholipid-transporting ATPase ID, transcript variant X12
phospholipid-transporting ATPase ID, transcript variant X1
phospholipid-transporting ATPase ID, transcript variant X3
phospholipid-transporting ATPase ID, transcript variant X6
phospholipid-transporting ATPase ID, transcript variant X5
phospholipid-transporting ATPase ID, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
phospholipid-transporting ATPase ID, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
phospholipid-transporting ATPase ID isoform X7
phospholipid-transporting ATPase ID isoform X6
phospholipid-transporting ATPase ID isoform X4
phospholipid-transporting ATPase ID isoform X3
phospholipid-transporting ATPase ID isoform X2
phospholipid-transporting ATPase ID isoform X1
phospholipid-transporting ATPase ID isoform X5
autophagy-related protein 13, transcript variant X2
autophagy-related protein 13, transcript variant X1
autophagy-related protein 13 homolog isoform X2
proton-coupled amino acid transporter-like protein pathetic, transcript variant X2
proton-coupled amino acid transporter-like protein pathetic isoform X2
proton-coupled amino acid transporter-like protein pathetic, transcript variant X1
proton-coupled amino acid transporter-like protein pathetic isoform X1
proton-coupled amino acid transporter-like protein pathetic, transcript variant X3
proton-coupled amino acid transporter-like protein pathetic isoform X3
coiled-coil domain-containing protein 93, transcript variant X1
coiled-coil domain-containing protein 93, transcript variant X2
coiled-coil domain-containing protein 93 isoform X1
coiled-coil domain-containing protein 93 isoform X2
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform, transcript variant X1
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform, transcript variant X2
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform, transcript variant X4
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform isoform X1
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform isoform X2
phosphorylase b kinase gamma catalytic chain, liver/testis isoform isoform X4
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform, transcript variant X3
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform isoform X3
max-binding protein MNT-like, transcript variant X3
max-binding protein MNT-like, transcript variant X13
max-binding protein MNT-like, transcript variant X18
max-binding protein MNT-like, transcript variant X4
max-binding protein MNT-like, transcript variant X8
max-binding protein MNT-like, transcript variant X9
max-binding protein MNT-like, transcript variant X1
max-binding protein MNT-like, transcript variant X10
max-binding protein MNT-like, transcript variant X14
max-binding protein MNT-like, transcript variant X15
max-binding protein MNT-like, transcript variant X7
max-binding protein MNT-like, transcript variant X12
max-binding protein MNT-like, transcript variant X17
max-binding protein MNT-like, transcript variant X5
max-binding protein MNT-like, transcript variant X6
max-binding protein MNT-like, transcript variant X2
lateral signaling target protein 2 homolog isoform X1
polyhomeotic-proximal chromatin protein-like isoform X2
max-binding protein MNT-like, transcript variant X11
max-binding protein MNT-like, transcript variant X16
lateral signaling target protein 2 homolog isoform X3
polyhomeotic-proximal chromatin protein-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
phospholipase DDHD1-like, transcript variant X1
phospholipase DDHD1-like, transcript variant X3
phospholipase DDHD1-like, transcript variant X2
uncharacterized LOC124431131, transcript variant X1
uncharacterized LOC124431131, transcript variant X4
uncharacterized LOC124431131, transcript variant X2
uncharacterized LOC124431131, transcript variant X5
uncharacterized protein LOC124431131 isoform X1
uncharacterized protein LOC124431131 isoform X4
uncharacterized protein LOC124431131 isoform X5
uncharacterized LOC124431131, transcript variant X3
uncharacterized protein LOC124431131 isoform X2
uncharacterized protein LOC124431131 isoform X3
cationic amino acid transporter 2, transcript variant X2
cationic amino acid transporter 2, transcript variant X1
cationic amino acid transporter 2 isoform X1
cationic amino acid transporter 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein kinase C, brain isozyme, transcript variant X1
protein kinase C, brain isozyme, transcript variant X2
protein kinase C, brain isozyme isoform X1
protein kinase C, brain isozyme isoform X2
protein kinase C, brain isozyme, transcript variant X3
protein kinase C, brain isozyme isoform X3